Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

Presentation TVT 2017

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Presenter: David J. Cohen, Jeffrey J. Popma, Robert O. Bonow

June 16, 2017

Presentation TVT 2017

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Philippe Généreux

June 16, 2017

Presentation TVT 2017

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem

June 16, 2017

Presentation TVT 2017

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

Presenter: David J. Cohen, Jeffrey J. Popma, Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani

June 16, 2017

Presentation TVT 2017

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Michael J. Reardon

June 16, 2017

Presentation TVT 2017

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Presenter: Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Presenter: Raj Makkar

June 16, 2017

Presentation TVT 2017

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

Presenter: Jean-Michel Paradis

June 16, 2017

Presentation TVT 2017

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

Presenter: Brij Maini

June 16, 2017

Presentation TVT 2017

TAV in Mitral Surgical Valves and Rings: Role of Imaging for Patient and Prosthesis Selection

Presenter: Mark Reisman, Vinayak Bapat

June 16, 2017

Presentation TVT 2017

Frequency and Clinical Management Issues in TAVR Patients

Presenter: John G. Webb

June 16, 2017

Presentation TVT 2017

TAV in Mitral Surgical Valves and Rings: Lessons From the VIVID Registry

Presenter: Mark Reisman, Danny Dvir

June 16, 2017

Presentation TVT 2017

A Critical Appraisal of REPRISE III

Presenter: Axel Linke, Jeffrey J. Popma, Raj Makkar

June 15, 2017

Presentation TVT 2017

The REPRISE III LBCT: A Randomized Trial Comparing LOTUS vs Self-Expanding CoreValve in High-Risk Aortic Stenosis Patients

Presenter: Axel Linke, Jeffrey J. Popma, Michael J. Reardon

June 15, 2017

Presentation TVT 2017

The Imaging Conundrum of Bicuspid Aortic Valve Disease - Almost 50 Shades of Gray!

Presenter: Robert O. Bonow, Martin B. Leon, Nicolo Piazza

June 15, 2017

Presentation TVT 2017

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Martin B. Leon, Philippe Généreux

June 15, 2017

Advertisement

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

TAV in Mitral Surgical Valves and Rings: Role of Imaging for Patient and Prosthesis Selection

Frequency and Clinical Management Issues in TAVR Patients

TAV in Mitral Surgical Valves and Rings: Lessons From the VIVID Registry

A Critical Appraisal of REPRISE III

The REPRISE III LBCT: A Randomized Trial Comparing LOTUS vs Self-Expanding CoreValve in High-Risk Aortic Stenosis Patients

The Imaging Conundrum of Bicuspid Aortic Valve Disease - Almost 50 Shades of Gray!

Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content